Age-Dependent Allergic Asthma Development and Cystathionine Gamma-Lyase Deficiency

Peipei Wang1, Lingyun Wu2,3, Yongjun Ju4

  • 11 Department of Biology, Lakehead University , Thunder Bay, Canada .

Insights

Lower cystathionine gamma-lyase (CSE) expression and hydrogen sulfide (H2S) production in young individuals contribute to allergic asthma. H2S supplementation may offer a new strategy for asthma prevention and treatment.

Area of Science:

  • Biochemistry
  • Immunology
  • Respiratory Medicine

Background:

  • Allergic asthma prevalence is higher in children than adults, but pathogenic mechanisms remain unclear.
  • Cystathionine gamma-lyase (CSE) catalyzes hydrogen sulfide (H2S) production, a molecule implicated in various physiological processes.

Purpose of the Study:

  • To investigate the role of age-dependent CSE expression in the development of allergic asthma.
  • To determine if H2S production influences the severity of allergic asthma symptoms.

Main Methods:

  • Induction of allergic asthma in young and old wild-type (WT) and CSE knock-out (KO) mice.
  • Measurement of CSE expression, H2S production, and type-2 immunoreaction.
  • Assessment of splenocyte differentiation and GATA3 translocation.
  • Evaluation of H2S supplementation effects.

Main Results:

  • Young WT mice exhibited lower CSE expression and H2S production, correlating with more severe asthma symptoms and heightened type-2 immunoreaction compared to old WT mice.
  • H2S supplementation ameliorated asthma symptoms in young WT mice.
  • CSE-KO mice showed a loss of age-dependent asthma propensity but overall more severe asthma.
  • H2S donors inhibited splenocyte differentiation into type-2 cytokine-producing cells and GATA3 nuclear translocation.

Conclusions:

  • Reduced CSE expression and H2S production at a young age enhance type-2 immunoreaction, leading to a higher incidence of allergic asthma.
  • H2S levels may serve as a biomarker for asthma development.
  • H2S-based strategies show potential for asthma prevention and treatment.
Abstract

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
966
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.1K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
593